NCT06411925

The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients

A Multi-center, Randomized, Double-blinded, Active-controlled, Non-inferiority, Phase 4 Trial to Evaluate the Efficacy and Safety of Atock Dry Syrup Sama With Acute Bronchitis Patients

• Status: Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 296 (estimated)
• Sponsor: SamA Pharmaceutical Co., Ltd · Industry
• Sex: All
• Age: 6 Months – 11 Years
• Healthy volunteers: Not accepted

Summary

Clinical Study to Evaluate the Efficacy and Safety of Atock Dry Syrup with Acute bronchial Patients

Conditions

• Acute Bronchitis

Interventions

Type	Name	Description
DRUG	Atock Dry Syrup with placebo patch	Atock Dry syrup (TID) with placebo patch (QD)
DRUG	Tulobuterol patch with placebo dry syrup	Tulobuterol patch (QD) with placebo dry syrup (TID)

Timeline

• Start date: 2023-11-10
• Primary completion: 2027-07-01
• Completion: 2027-09-01
• First posted: 2024-05-13
• Last updated: 2025-09-23

Locations

1 site across 1 country: South Korea